RHON-KLINIKUM AG (RHK) AI Stock Analysis

• Market Cap: €836.73M
• Dividend Yield: 0.77%
• Average Volume (3M): 955.00
• Price to Earnings (P/E): 20.4
• Beta (1Y): -0.05
• Revenue Growth: 9.10%
• EPS Growth: -15.07%
• Country: DE
• Employees: 18,819
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): 0.15
• Shares Outstanding: 66,962,470
• 10 Day Avg. Volume: 528
• 30 Day Avg. Volume: 955
• PEG Ratio: -1.23
• Price to Book (P/B): 0.64
• Price to Sales (P/S): 0.44
• P/FCF Ratio: -24.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.76
• Revenue Forecast (FY): €1.79B

• Rating: 57 Neutral
• Price Target: €12.50 ▼(-3.10% Downside)
• Action: Downgraded Date: 03/28/26
• Date: Action: Downgraded 03/28/26

The score is anchored by a strong, low-leverage balance sheet, but is held back by weaker 2025 profitability and negative free cash flow. Technicals are also unfavorable with the stock trading below major moving averages and negative momentum, while valuation looks only moderate with a low dividend yield.

Positive Factors

Conservative balance sheet

The company’s low leverage and rising equity provide a durable financial cushion that supports operating flexibility and downturn resilience. With total debt reduced and sizable equity, RHÖN-KLINIKUM can absorb temporary cash-flow variability, invest selectively, and access capital without immediate solvency pressure.

Negative Factors

Sharp EBIT collapse in 2025

A near-total collapse in operating profit signals structural margin pressure or major one-off costs that materially reduce operating leverage. Persistently depressed EBIT undermines reinvestment, raises sensitivity to reimbursement changes, and could force cost restructuring or limit strategic initiatives over the medium term.

RHON-KLINIKUM AG Business Overview & Revenue Model

Company Description

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand sur...

Read more

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand sur...

How the Company Makes Money

RHÖN-KLINIKUM AG makes money primarily by delivering medical treatment services through its hospitals and billing payers for patient care. Revenue is generated from inpatient hospital stays (e.g., admissions, procedures, surgeries, intensive care,...

Read more

RHÖN-KLINIKUM AG makes money primarily by delivering medical treatment services through its hospitals and billing payers for patient care. Revenue is generated from inpatient hospital stays (e.g., admissions, procedures, surgeries, intensive care,...

RHON-KLINIKUM AG Financial Statement Overview

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.65B	1.94B	1.60B	1.73B	1.45B	1.40B
Gross Profit	499.52M	167.75M	171.82M	202.88M	999.52M	182.63M
EBITDA	115.77M	69.40M	122.23M	116.58M	106.15M	100.21M
Net Income	37.68M	34.47M	43.35M	38.71M	25.14M	28.30M
Balance Sheet
Total Assets	1.87B	1.82B	1.86B	1.77B	1.70B	1.67B
Cash, Cash Equivalents and Short-Term Investments	346.19M	329.85M	426.66M	342.84M	296.33M	292.12M
Total Debt	146.87M	122.17M	149.60M	149.84M	158.20M	159.76M
Total Liabilities	535.79M	467.50M	530.51M	490.30M	453.51M	440.82M
Stockholders Equity	1.30B	1.32B	1.30B	1.25B	1.22B	1.20B
Cash Flow
Free Cash Flow	0.00	-34.60M	57.20M	46.20M	-16.90M	19.70M
Operating Cash Flow	0.00	64.50M	127.60M	109.00M	60.30M	97.50M
Investing Cash Flow	0.00	-132.10M	-50.40M	40.90M	-105.20M	-58.30M
Financing Cash Flow	0.00	-42.00M	-3.30M	-21.20M	-4.10M	-3.90M

RHON-KLINIKUM AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 12.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:RHK, the sentiment is Negative. The current price of 12.9 is above the 20-day moving average (MA) of 12.66, above the 50-day MA of 12.89, and above the 200-day MA of 12.29, indicating a neutral trend. The MACD of -0.14 indicates Positive momentum. The RSI at 42.81 is Neutral, neither overbought nor oversold. The STOCH value of 42.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:RHK.

RHON-KLINIKUM AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
M12	80 Outperform	€276.81M	6.07	15.83%	2.80%	6.52%	7.17%
LIK	73 Outperform	€145.20M	8.54	22.77%	―	0.21%	7.53%
MED	65 Neutral	€168.15M	6.90	10.71%	1.12%	4.90%	―
FME	58 Neutral	€11.70B	12.14	7.26%	3.54%	2.10%	9.19%
RHK	57 Neutral	€836.73M	20.44	2.63%	0.77%	9.10%	-15.07%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
MAK	41 Neutral	€28.94M	-1.84	22.85%	―	6.87%	-94.85%